AstraZeneca – Our Place in the Breast Cancer Community
AstraZeneca has a more than 30-year history of helping people with cancer through our medicines, with patients always at the forefront of our efforts to understand and develop treatment options.
Our support this week for Metastatic Breast Cancer Awareness Day, October 13, is consistent with a commitment to the oncology community that has long extended beyond research and development to address a wide range of non-medical patient needs.
Since its inception in 1993, the AstraZeneca HealthCare Foundation has sponsored National Breast Cancer Awareness Month (NBCAM), which has been commemorated every October for more than 25 years. The activities that take place during this month have raised awareness about breast cancer, shared information on the disease, and provided greater access to screening services. AstraZeneca also assists cancer patients and caregivers in traversing the health care system through our support of the American Cancer Society’s innovative Patient Navigator and Hope Lodge programs.
The American Cancer Society Patient Navigator Program links individuals affected by cancer to education and support specialists – “patient navigators” – who guide patients and caregivers as they confront the psychosocial and financial challenges of a cancer journey. AstraZeneca Hope Lodges in Boston and Philadelphia offer cancer patients and loved ones with financial needs a free, temporary place to stay when their treatment takes them to these cities.
But gaps still exist. We want to provide more resources and more medical research for people with metastatic breast cancer, a form of advanced breast cancer. Metastatic breast cancer, also referred to as stage IV breast cancer, is diagnosed when cancer has spread from the breast to other parts of the body and is generally not curable.
AstraZeneca will continue to search for effective treatments while supporting important educational programs like NBCAM and patient initiatives like Patient Navigator and Hope Lodge.
Emily Denney, Senior Director, External Affairs at AstraZeneca